This trial has been completed.

Conditions alcohol consumption, alcohol abuse
Treatments sbirt training & support tool, waitlist control
Sponsor Oregon Center for Applied Science, Inc.
Collaborator National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Start date June 2016
End date November 2016
Trial size 330 participants
Trial identifier NCT02489032, 2R44AA021053, BIG Al 2


The goal of the proposed research is to complete the development of a web-based program to train Employee Assistance Program (EAP) and EAP-affiliated managed behavioral health organization (MBHO) practitioners to conduct screening, brief intervention, and referral to treatment (SBIRT) for problem alcohol use among working adults.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Primary purpose other
Masking no masking
The SBIRT Training & Support Tool has two components, both of which will be evaluated: (1) online SBIRT Training for EAP and behavioral health practitioners conducting alcohol SBIRT with their adult clients and (2) mobile/web interactive alcohol screening tools and brief intervention protocols to facilitate use of SBIRT by practitioners.
sbirt training & support tool
Program to train EAP/behavioral health practitioners in conducting alcohol SBIRT
Subjects randomized to the control condition will be placed on a wait-list and given access to the SBIRT Training & Support Tool after 3 months and completion of the 3-month follow-up assessment.
waitlist control
3-month wait-list and then provided access to the SBIRT training program

Primary Outcomes

SBIRT implementation
time frame: 3 months

Secondary Outcomes

Perceived Competence
time frame: 3 months
time frame: 3 months
time frame: 3 months

Eligibility Criteria

All participants at least 18 years old.

Inclusion Criteria: - EAP/BH practitioners will be employed at an EAP or behavioral health organization - have an e-mail account - access to high-speed Internet connection - speak and read English Exclusion Criteria: - younger than 18 - not an EAP practitioner - no access to e-mail - no access to the Internet - do not speak and read English

Additional Information

Official title Web-Based Training for EAP Alcohol Screening, Brief Intervention, and Refer
Principal investigator Amelia J Birney, MPH, MCHES
Description In Phase 2, the investigators propose to develop the SBIRT Training & Support Tool with two components: (1) online SBIRT Training for call-center and face-to-face practitioners conducting alcohol SBIRT and (2) SBIRT Support Tool with mobile/web interactive alcohol screening tools and brief intervention protocols to facilitate use of SBIRT by practitioners. The SBIRT Training component will provide practitioners with the skills, knowledge, motivation, and self-efficacy to: (a) screen their clients for unhealthy alcohol use with validated screening tools; (b) provide brief, motivational interviewing-informed intervention; and (c) make appropriate referrals. The training program will incorporate the Phase 1 content and expand the curriculum to include the use of additional validated alcohol screening tools. Content for alcohol SBIRT will be derived from NIAAA evidence-based materials. The SBIRT Support Tool will provide a mobile/web interface for practitioners to use interactive screening and brief intervention forms with (a) prompts for validated questions in the screening or brief intervention; (b) motivational interviewing-informed dialogue suggestions; (c) online resources (i.e., standard drink list; importance, confidence rulers); and (d) alcohol education and referral information. The practitioner will use the SBIRT Support Tool to (a) screen clients for alcohol use with interactive validated screening tools; (b) provide brief intervention for individuals based on their screening score; and (c) provide referral to treatment for individuals based on their screening score.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Oregon Center for Applied Science, Inc..